Screener
Myriad Genetics MYGN Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $32.6 | $30.0 |
| Accrued liabilities | 90.5 | 96.9 |
| Current maturities of operating lease liabilities | 7.1 | 6.9 |
| Total current liabilities | 130.2 | 133.8 |
| Long-term debt | 120.3 | 119.9 |
| Noncurrent operating lease liabilities | 84.1 | 83.0 |
| Other long-term liabilities | 1.7 | 1.9 |
Item 1. Financial Statements.
FAQ
- What is Myriad Genetics's operating lease liabilities (current)?
- Myriad Genetics (MYGN) reported operating lease liabilities (current) of $7.1M in Q1 2026.
- How has Myriad Genetics's operating lease liabilities (current) changed year-over-year?
- Myriad Genetics's operating lease liabilities (current) decreased by 34.9% year-over-year, from $10.9M to $7.1M.
- What is the long-term trend for Myriad Genetics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Myriad Genetics's operating lease liabilities (current) has grown at a -12.7% compound annual growth rate (CAGR), from $13.6M to $6.9M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Myriad Genetics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude